Same Weight Loss, Different Liver Outcomes
Two people can lose the same amount of weight and end up with meaningfully different livers. That is the finding from a controlled feeding trial led by Washington University School of Medicine, in which adults with obesity, prediabetes, and fatty liver disease were assigned to one of three diets and brought to the same weight target.
All three groups shed about 10 percent of their starting weight over roughly five months, and all three improved muscle insulin sensitivity by about 50 percent. Liver fat was where they diverged: it fell by an average of 67 percent in the ketogenic group, compared with 45 percent in both the Mediterranean and low-fat plant-forward groups. About half the ketogenic group no longer met criteria for prediabetes by the end, versus 29 percent on the Mediterranean diet and 7 percent on the plant-forward plan.
It's worth noting upfront: 55 adults with metabolically unhealthy obesity were randomly assigned, and the analysis covers 42 participants. That is a small trial, and it shapes how much weight the percentages can carry.
Why This Trial Design Matters
Most diet research compares plans that produce different amounts of weight loss, making it impossible to separate the effect of the food from the effect of the pounds. This trial removed that problem by adjusting calories individually so every participant reached roughly 10 percent weight loss.
Researchers also supplied 100 percent of participants' food and met with them weekly alongside a study dietitian. That level of control is why the trial can say something specific about diet composition — and why the results should not be read as a forecast of what happens when someone attempts keto alone with supermarket groceries.
The equal improvement in muscle insulin sensitivity across all three arms is the quiet finding worth keeping. It suggests weight loss itself, not the macronutrient mix, mattered there.
The Hormonal Mechanism Behind the Difference
Where the ketogenic diet pulled ahead was the liver and daily blood sugar control. Insulin sensitivity in liver cells — which governs how well the liver suppresses glucose production — improved two to three times more on the ketogenic plan. Twenty-four-hour blood glucose fell 20 percent from baseline on keto versus 8 percent on the others. Circulating insulin across the day dropped 74 percent, compared with 44 percent on the Mediterranean diet and 27 percent on the high-carbohydrate one.
Participants on the ketogenic diet also showed the largest rise in glucagon, a hormone that helps mobilize fat stored in the liver. Both changes fit the liver fat result.
"We know weight loss can improve metabolic health in people who are obese," said Samuel Klein of Washington University School of Medicine in St. Louis, the study's senior author. "Our data suggest that if you have high liver fat content and prediabetes, reducing carbohydrate intake can have important therapeutic effects on metabolism beyond just weight loss alone."
First author Max Petersen added: "The most surprising finding was that participants in the ketogenic diet group didn't experience an increase in blood fat or cholesterol levels despite consuming the most fat." However, blood lipid responses to very low carbohydrate diets vary considerably between individuals, and some people experience substantial LDL increases. A group average of no change does not mean no individual changed.
From Trial to Real Life
Fatty liver disease affects roughly 75 percent of adults with obesity worldwide and has become the fastest-growing cause of chronic liver disease and cirrhosis. It often produces no symptoms until it has progressed. Clinicians routinely recommend low-fat, low-carbohydrate, or Mediterranean patterns without strong evidence that one offers metabolic advantages beyond the weight lost — which is exactly what this trial set out to address.
The reasons for restraint are practical. Forty-two analyzed participants is too few to detect uncommon adverse effects or to show that results generalize across age, sex, ethnicity, and baseline health. Five months does not tell us whether liver fat stays down, whether people can sustain very low carbohydrate intake, or whether the advantage persists after weight stabilizes. Participants got free food and weekly professional support — conditions that do not exist outside a trial.
Some groups should not attempt a ketogenic diet without medical supervision, including people with certain kidney conditions, people who are pregnant, people with a history of disordered eating, and people on diabetes medications, where carbohydrate restriction can cause dangerously low blood sugar unless doses are adjusted.
Petersen also situated the finding alongside current obesity treatment: "Many metabolically unhealthy patients also are candidates for GLP-1 medicines, which have been very useful tools for helping people lose weight. But our results show that choice of diet remains important because it has an impact on specific health outcomes that go beyond weight loss alone."
Current Guidance and What's Still Needed
No professional body has changed its dietary recommendations because of this trial, and none should on the basis of 42 participants. Guidance for fatty liver disease still centers on weight loss of roughly 7 to 10 percent, physical activity, alcohol reduction, and management of diabetes and lipids.
What would change the picture is a larger, longer trial measuring whether reduced liver fat translates into fewer cases of cirrhosis, liver cancer, and cardiovascular events. Imaging-based liver fat is a surrogate marker, not an outcome.
For someone with fatty liver disease, the useful takeaway is narrow and real: how you lose weight may matter, not only how much. That is worth raising at your next appointment, alongside a request for the imaging or fibrosis assessment that tracks whether anything is actually improving.
The Xiaoshu Health App can sync with Apple Health to track relevant metrics, helping you record weight, blood sugar, and metabolic changes for scientific fatty liver risk management.
Key Questions Answered
- What did the trial compare? Fifty-five adults with obesity, prediabetes, and fatty liver disease were randomly assigned to a ketogenic, Mediterranean, or low-fat plant-forward diet, with results reported for 42. Calories were adjusted individually so all groups reached about 10 percent weight loss.
- How much did liver fat drop? By an average of 67 percent in the ketogenic group and 45 percent in the Mediterranean and plant-forward groups, despite similar weight loss across all three.
- Does this prove keto is the best diet? No. This is a small trial; larger, longer studies are needed to confirm whether reduced liver fat translates into fewer clinical events.